Showing results (1361-1370 of 1,893) with videos related to
Sort By:
Pageof 190
Immunotherapy|May 4, 2026
ELAVL1 increases macrophage M1 polarization via upregulating S100A8 to promote Crohn's disease progressionLin Jia, Yingtai Chen, Ying LuImmunotherapy|May 13, 2014
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis preventionSusanna Esposito, Luca Castellazzi, Annalisa Bosco, et al.Immunotherapy|November 22, 2016
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosisUyanga Batbold, Dmytro O Butov, Galyna A Kutsyna, et al.Immunotherapy|October 10, 2026
Real-world efficacy and safety of neoadjuvant immunochemotherapy in patients with triple-negative breast cancerRuoxi Xu, Pinchao Fan, Yiqiu Liu, et al.Immunotherapy|December 7, 2022
Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanomaBeatrix Ványai, Yi-Che Chang Chien, Lívia Beke, et al.Immunotherapy|December 13, 2022
Plain language summary of the VOLTAIRE-CD study in people with moderate-to-severe active Crohn's diseaseStephen HanauerImmunotherapy|October 13, 2020
Clinical and biological activity of rituximab in the treatment of pemphigusGérôme Bohelay, Frédéric Caux, Philippe MusetteImmunotherapy|October 13, 2020
From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancerRosa Tambaro, Marilena Di Napoli, Carmela Pisano, et al.Immunotherapy|March 28, 2020
Ex vivo-generated dendritic cell-based vaccines in melanoma: the role of nanoparticulate delivery systemsMona Yazdani, Mahmoud Reza Jaafari, Javad Verdi, et al.Immunotherapy|March 28, 2020
The characteristic of tumor immune microenvironment in pulmonary carcinosarcomaYanhong Cen, Zhao Huang, Jiangbo Ren, et al.Pageof 190